Silencing of necroptosis related genes in endocrine-resistant breast cancer cells causes PFKFB3 induced arrest of necroptosis and contributes to resistance

被引：0
|
作者：
Jones, Brandon C.
Onal, Tuna
Sengupta, Surojeet
Sevigny, Catherine M.
Jin, Lu
Pohlmann, Paula R.
Shajahan-Haq, Ayesha
Clarke, Robert
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3281
引用
收藏
页数：2
相关论文
共 25 条
  • [1] Pfkfb3 inhibition significantly decreases endocrine-resistant breast cancer growth and induces necroptotic cell death
    Jones, Brandon C.
    Sengupta, Surojeet
    Sevigny, Catherine M.
    Jin, Lu
    Pohlmann, Paula R.
    Shajahan-Haq, Ayesha
    Clarke, Robert
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [2] Necroptosis pathway blockage attenuates PFKFB3 inhibitor-induced cell viability loss and genome instability in colorectal cancer cells
    Yan, Siyuan
    Li, Qianqian
    Zhang, Deru
    Wang, Xiaowen
    Xu, Yang
    Zhang, Cong
    Guo, Dongli
    Bao, Yonghua
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (05): : 2062 - +
  • [3] PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production
    Ge, X.
    Cao, Z.
    Gu, Y.
    Wang, F.
    Li, J.
    Han, M.
    Xia, W.
    Yu, Z.
    Lyu, P.
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (06) : 119 - 125
  • [4] Growth hormone receptor (GHR) expression confers resistance to ruxolitinib in endocrine-resistant breast cancer cells
    Holtz, Anja N.
    Yee, Douglas
    Beckwith, Heather
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [5] A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells
    Huang, Ou
    Xie, Zuoquan
    Zhang, Weili
    Lou, Ying
    Mao, Yan
    Liu, Hongchun
    Jiang, Min
    Shen, Kunwei
    [J]. ONCOLOGY REPORTS, 2014, 32 (02) : 627 - 634
  • [6] Effects of PI3K inhibitors on endocrine-resistant cell lines and differences in the characteristics of ER positive breast cancer cells after acquired resistance to the inhibitors
    Tokuda, Emi
    Komatsu, Takayuki
    Sasaki, Shunta
    Tsuboi, Kouki
    Nakamura, Misato
    Iida, Masafumi
    Niwa, Toshifumi
    Saito, Mitsue
    Hayashi, Shin-Ichi
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [7] The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells
    Yang, Yini
    Choppavarapu, Lavanya
    Fang, Kun
    Naeini, Alireza S.
    Nosirov, Bakhtiyor
    Li, Jingwei
    Yang, Ke
    He, Zhijing
    Zhou, Yufan
    Schiff, Rachel
    Li, Rong
    Hu, Yanfen
    Wang, Junbai
    Jin, Victor X.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2020, 1863 (11):
  • [8] Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients
    Abdi, Sheyda
    Montazeri, Vahid
    Garjani, Alireza
    Shayanfar, Ali
    Pirouzpanah, Saeed
    [J]. MOLECULAR BIOLOGY REPORTS, 2020, 47 (04) : 2459 - 2473
  • [9] Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients
    Sheyda Abdi
    Vahid Montazeri
    Alireza Garjani
    Ali Shayanfar
    Saeed Pirouzpanah
    [J]. Molecular Biology Reports, 2020, 47 : 2459 - 2473
  • [10] RETRACTED: Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells (Retracted Article)
    Sun, Yiming
    Pan, Qiong
    Ma, Linyan
    Chen, Chao
    Zhao, Surong
    Liu, Hao
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
123